Botulinum toxin A for refractory OAB and idiopathic urinary retention: Can phenotyping improve outcome for patients: ICI-RS 2019?

Sachin Malde Apostolos ApostilidisCaroline SelaiMohammad Sajjad Rahnamai T A T MarcelissenLinda CardozoThelma Lovick

Published in: Neurourology and urodynamics (2019)

Advances in basic science research into the mechanism of action of BTX-A have improved our understanding of the pathophysiology of OAB and may lead to novel ways to phenotype patients. Psychological assessment is another way in which phenotyping may be improved. Areas for further research are proposed.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
botulinum toxin
peritoneal dialysis
prognostic factors
public health
high throughput
patient reported outcomes